@prefix dcterms: .
@prefix this: .
@prefix sub: .
@prefix np: .
@prefix npx: .
@prefix xsd: .
@prefix orcid: .
@prefix rdfs: .
@prefix fip: .
@prefix prov: .
sub:Head {
this: a np:Nanopublication;
np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubinfo .
}
sub:assertion {
sub:LACDR-DDS-CTDS a fip:FAIR-Implementation-Community;
dcterms:isPartOf ;
rdfs:comment "In this research group, headed by prof. dr. Bob van de Water, cell signaling programs that underlie adverse drug reactions as well as cancer development and progression are unraveled.";
rdfs:label "Cancer Therapeutics and Drug Safety, Division of Drug Discovery & Safety, LACDR, Leiden University";
rdfs:seeAlso ;
fip:has-research-domain .
}
sub:provenance {
sub:assertion dcterms:creator orcid:0000-0001-7525-9218 .
}
sub:pubinfo {
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCoKFb7LKlXyBB7BUvjFF9bDJNk0WxH3Xerr4H3v/VCiRVshEDl3BZVekbMMmdRe+TOPyc8AOLd9IAL2VfVVD/T0rmCHk7Pw7DQjI96mwyeXhE7f4g0WG5UT5Pxxm0Rzy7IrYnEaaVDs7dkZUt952M6qWlHfTwCQDcXJhZfLiXoMwIDAQAB";
npx:hasSignature "f/glNqNNjIOr7rP0fR/pKIoIAJZyoYkKvt4m2i07Dn/KqNGSM8D8/ltM28jtvLkSQGOOeE04eIlHs4kuRX0IQLx9Aa46y9XWs0P747Vs7TXOr+r/yGby1FvH3A5SqZHjyb2DkCcfDrp9vL8o8L1NV/9c64PnxYoJdKWHTfu+qQk=";
npx:hasSignatureTarget this: .
this: dcterms:created "2023-01-19T14:26:48Z"^^xsd:dateTime;
dcterms:creator ;
dcterms:license ;
npx:introduces sub:LACDR-DDS-CTDS;
prov:wasDerivedFrom .
}